, Tracking Stock Market Picks
Enter Symbol:
Quest Diagnostics Incorporated (DGX) [hlAlert]

down 15.14 %

Quest Diagnostics Incorporated (DGX) rated Underperform with price target $55 by BofA/Merrill

Posted on: Tuesday,  Dec 10, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Quest Diagnostics Incorporated (NYSE: DGX) on 12/10/2013, when the stock price was $58.62. Since
then, Quest Diagnostics Incorporated has gained 17.84% as of 01/15/2016's recent price of $69.08.
If you would have followed this BofA/Merrill's recommendation on DGX, you would have lost 15.14% of your investment in 766 days.

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2013 8:25 AM Sell
58.62 55.00
as of 12/13/2013
1 Week up  7.54 %
1 Month   
3 Months   
1 YTD up  7.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy